Genetic Technologies Limited (NASDAQ:GENE) has a beta value of 1.32 and has seen 4,106,758 shares traded in the recent trading session. The company, currently valued at $31.49 Million, closed the recent trade at $2.3422 per share which meant it gained $0.29 on the day or 14.63% during that session. The GENE stock price is -128.85% off its 52-week high price of $5.36 and 39.8% above the 52-week low of $1.41. If we look at the company’s 10-day average daily trading volume, we find that it stood at 767.47 Million shares traded. The 3-month trading volume is 1.33 Million shares.

The consensus among analysts is that Genetic Technologies Limited (GENE) is a Buy stock at the moment, with a recommendation rating of 0. None of the analysts rate the stock as a Sell, while none rate it as Overweight. None out of 1 have rated it as a Hold, with 1 advising it as a Buy. None have rated the stock as Underweight. The expected earnings per share for the stock is $0.

Genetic Technologies Limited (NASDAQ:GENE) trade information

Sporting 13.41% in the green today, the stock has traded in the green over the last five days, with the highest price hit on Monday, Jun 29 when the GENE stock price touched $2.48-9 or saw a rise of 9.77%. Year-to-date, Genetic Technologies Limited shares have moved 12.45%, while the 5-day performance has seen it change 2.18%. Over the past 30 days, the shares of Genetic Technologies Limited (NASDAQ:GENE) have changed 9.7%. Short interest in the company has seen 74.01 Million shares shorted with days to cover at 55.65.

Wall Street analysts have a consensus price target for the stock at $25.65, which means that the shares’ value could jump 995.12% from current levels. The projected low price target is $25.65 while the price target rests at a high of $25.65. In that case, then, we find that the current price level is +995.12% off the targeted high while a plunge would see the stock lose 995.12% from current levels.

Genetic Technologies Limited (GENE) estimates and forecasts

If we evaluate the company’s growth over the last 5-year and for the next 5-year period, we find that annual earnings growth was +49.7% over the past 5 years. Earnings growth for 2020 is a modest -9.6% while over the next 5 years, the company’s earnings are expected to increase by 0%.